Tecta



Indications and Reactions:

Role Indications Reactions
Primary
Gastrooesophageal Reflux Disease 40.7%
Hypertension 13.0%
Hypothyroidism 5.6%
Abdominal Pain Upper 3.7%
Gastritis 3.7%
Gastritis Erosive 3.7%
Oesophagitis 3.7%
Peptic Ulcer 3.7%
Ulcer 3.7%
Antacid Therapy 1.9%
Convulsion 1.9%
Erosive Duodenitis 1.9%
Erosive Oesophagitis 1.9%
Fungal Infection 1.9%
Gastric Disorder 1.9%
Gastric Ph Decreased 1.9%
Gastrooesophagitis 1.9%
Hypercholesterolaemia 1.9%
Migraine 1.9%
Somnolence 11.4%
Panic Disorder 8.6%
Thrombocytopenia 8.6%
Dyspnoea 5.7%
Pruritus 5.7%
Rash Generalised 5.7%
Urticaria 5.7%
Vision Blurred 5.7%
Visual Impairment 5.7%
Vomiting 5.7%
Weight Decreased 5.7%
Abnormal Dreams 2.9%
Acute Febrile Neutrophilic Dermatosis 2.9%
Arrhythmia 2.9%
Chest Discomfort 2.9%
Feeling Hot 2.9%
Haemorrhage 2.9%
Hepatic Neoplasm 2.9%
Hiatus Hernia 2.9%
Hypertension 2.9%
Secondary
Gastrooesophageal Reflux Disease 17.0%
Product Used For Unknown Indication 11.4%
Gastritis 10.2%
Hypertension 9.1%
Depression 8.0%
Drug Dependence 6.8%
Gastric Disorder 5.7%
Gastric Polyps 5.7%
Panic Disorder 4.5%
Gastric Ulcer 3.4%
Anticoagulant Therapy 2.3%
Gastritis Prophylaxis 2.3%
Hypothyroidism 2.3%
Migraine 2.3%
Prophylaxis 2.3%
Vasodilation Procedure 2.3%
Abdominal Pain Upper 1.1%
Antacid Therapy 1.1%
Anxiety 1.1%
Cardiac Disorder 1.1%
Petechiae 14.3%
Premature Baby 14.3%
Somnolence 14.3%
Venous Occlusion 14.3%
Helicobacter Infection 7.1%
Myalgia 7.1%
Premature Separation Of Placenta 7.1%
Rheumatoid Factor Increased 7.1%
Urinary Incontinence 7.1%
Weight Decreased 7.1%
Concomitant
Product Used For Unknown Indication 28.4%
Crohn's Disease 18.9%
Rheumatoid Arthritis 13.8%
Gastrooesophageal Reflux Disease 4.7%
Hypertension 4.5%
Premedication 3.3%
Hepatitis C 2.8%
Adverse Event 2.7%
Diabetes Mellitus 2.7%
Pain 2.5%
Ankylosing Spondylitis 2.2%
Vitamin Supplementation 2.2%
Osteoporosis 2.0%
Colitis Ulcerative 1.8%
Asthma 1.7%
Psoriatic Arthropathy 1.5%
Blood Cholesterol Increased 1.3%
Sleep Disorder 1.2%
Depression 1.0%
Insomnia 1.0%
Weight Decreased 15.8%
Vomiting 12.3%
Headache 5.3%
Joint Swelling 5.3%
Nephrolithiasis 5.3%
Neuroleptic Malignant Syndrome 5.3%
Vision Blurred 5.3%
Anaemia 3.5%
Arthritis 3.5%
Cholelithiasis 3.5%
Death 3.5%
Drug Ineffective 3.5%
Hypoaesthesia 3.5%
Hypotension 3.5%
Inappropriate Schedule Of Drug Administration 3.5%
Infusion Related Reaction 3.5%
Pain 3.5%
Pituitary-dependent Cushing's Syndrome 3.5%
Pneumonia 3.5%
Pollakiuria 3.5%
Interacting
Blood Thyroid Stimulating Hormone Increased 33.3%
Dysphonia 33.3%
Gastrooesophageal Reflux Disease 33.3%
Hypotension 100.0%